Rechallenging with anti-PD-1 therapy in advanced renal cell carcinoma.

Lancet

Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06511, USA; Department of Pathology, Yale School of Medicine, New Haven, CT 06511, USA; Department of Urology, Yale School of Medicine, New Haven, CT 06511, USA; Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale School of Medicine, New Haven, CT 06511, USA. Electronic address:

Published: October 2024

Download full-text PDF	Source
http://dx.doi.org/10.1016/S0140-6736(24)01866-X	DOI Listing

Publication Analysis

Top Keywords

rechallenging anti-pd-1

anti-pd-1 therapy

therapy advanced

advanced renal

renal cell

cell carcinoma

rechallenging

therapy

advanced

renal

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!